Jove
Visualize
联系我们

相关实验视频

发展生物学. 一些零件和碎片.

Alessandro Minelli1

  • 1Department of Biology, University of Padova, I 35131 Padova, Italy. alessandro.minelli@unipd.it

Science (New York, N.Y.)
|December 4, 2004
PubMed
概括

No abstract available in PubMed .

相关实验视频

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.

Cancers·2025
Same author

Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study.

Cancers·2025
Same author

Exploring the Prognostic and Predictive Impact of Genomic Loss of Heterozygosity and Homologous Recombination Deficiency Alterations in Patients With Metastatic Colorectal Cancer.

JCO precision oncology·2025
Same author

Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort.

Clinical colorectal cancer·2025
Same author

Prognostic impact of depth of response and early tumour shrinkage in patients with <i>BRAF</i> <sup></sup> -mutated metastatic colorectal cancer treated with targeted therapy.

Therapeutic advances in medical oncology·2025
Same author

Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study.

Current oncology (Toronto, Ont.)·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策